Journal
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Volume 69, Issue 2, Pages 269-277Publisher
SPRINGER HEIDELBERG
DOI: 10.1007/s00228-012-1331-5
Keywords
Pregnancy; Ginger; Nausea; Herbal medicine; Congenital malformations; Pregnancy outcome
Categories
Funding
- Norwegian Ministry of Health
- Ministry of Education and Research
- NIH/NIEHS [NO-ES-75558]
- NIH/NINDS [1 UO1 NS 047537-01]
- Norwegian Research Council/FUGE [151918/S10]
Ask authors/readers for more resources
The objective of the study was to examine the safety of ginger use during pregnancy on congenital malformations and selected pregnancy outcomes. The Norwegian Mother and Child Cohort study, a large population-based cohort, provided the data used in this study. Our study population consisted of 68,522 women. Data on ginger use and socio-demographic factors were retrieved from three self-administered questionnaires completed by the women during weeks 17 and 30 of the pregnancy and when their child was 6 months old. Data on pregnancy outcomes were provided by the Medical Birth Registry of Norway. Among the 68,522 women in the study, 1,020 (1.5 %) women reported using ginger during pregnancy. The use of ginger during pregnancy was not associated with any increased risk of congenital malformations. No increased risk for stillbirth/perinatal death, preterm birth, low birth weight, or low Apgar score was detected for the women exposed to ginger during pregnancy compared to women who had not been exposed. Use of ginger during pregnancy does not seem to increase the risk of congenital malformations, stillbirth/perinatal death, preterm birth, low birth weight, or low Apgar score. This finding is clinically important for health care professionals giving advice to pregnant women with NPV.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available